Tag: OTCMKTS: ATOS

Business

Atossa Therapeutics Inc (OTCMKTS: ATOS) Releases The Final Data of Their Endoxifen Breast Cancer Study (Phase 2)

Atossa Therapeutics Inc (OTCMKTS: ATOS) is a clinical-stage biopharma organization, is looking to develop and discover innovative medications, and is currently concentrating on coronavirus and breast cancer, has been conducting Phase 2 of their Endoxifen Breast Cancer study and recently released their final data concerning their Phase 2 trials. The […]